Navigation Links
Rise in Opioid Use for Abdominal Pain Points to Larger Problem Warns Waismann Method Medical Director
Date:12/6/2011

BEVERLY HILLS, Calif., Dec. 6, 2011 /PRNewswire/ -- A new study, released by the American Gastroenterological Association, shows outpatient clinics across the United States witnessed opiate prescriptions for chronic abdominal pain more than double between 1997 and 2008.  Dr. Michael Lowenstein, co-medical director for the Waismann Method, an advanced procedure for rapid opiate detox, warns that this increase signals the gaining popularity of prescription painkillers and its general use to treat any type of pain, regardless of the source or cause.

"Potential side effects of prescription painkillers include gastrointestinal symptoms, like constipation, nausea, vomiting, bloating and cramping, which can lead to more severe abdominal pain," said Dr. Lowenstein.  "The fact that physicians are prescribing opiate medications for persistent abdominal pain indicates that prescription painkillers have become a go-to treatment to instantly satisfy patients' demands, without really understanding if there are advantages of their use. This study indicates physicians may be prescribing opiate painkillers for almost any symptom or condition without fully evaluating the risks and potentially negative consequences for patients."

According to the study, while outpatient visits for chronic abdominal pain decreased between 1997 and 2008 from 14.8 million to 12.2 million visits, opiate prescriptions to treat these patients significantly rose.  Opiates were prescribed for 5.9 percent of chronic abdominal pain cases from 1997 through 1999.  From 2006 through 2008, the number of chronic abdominal pain cases treated with prescription painkillers rose to 12.2 percent.  The study also shows that while opiate prescriptions were l
'/>"/>

SOURCE Waismann Method
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
3. QRxPharma Doses First Patients in Phase III Clinical Trial Program for its Dual Opioid Pain Therapy
4. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
5. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
6. QRxPharma Releases Additional Phase 3 Data for Q8003IR Dual Opioid Pain Therapy
7. Study Shows Leconotide, an Investigative Calcium Channel Blocker, Has Potential as a Selective, Efficacious, Non-Opioid Pain Treatment
8. Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
9. QRxPharma Successfully Completes Comparative Study for Dual-Opioid(TM) Pain Therapy
10. One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials
11. Classwide Opioids REMS: A Good Idea, Implement Carefully
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2015)... 30, 2015  Astellas Pharma Inc. (TSE: 4503) today ... on the safety, tolerability and efficacy of ASP2215, a ... refractory (R/R) acute myeloid leukemia (AML) were presented during ... Clinical Oncology,s (ASCO) annual meeting in Chicago ... kinase inhibitor of FLT3 and AXL, which are involved ...
(Date:5/30/2015)... Wash. and VANCOUVER, British Columbia ... Inc. (NASDAQ: OGXI ) announced today that results ... trial showed a benefit with custirsen therapy in men ... poor prognosis. The analysis, exploring the effect of clusterin ... that over 40 percent of men in the trial ...
(Date:5/30/2015)... y SPARTANBURG , Carolina ... - Nueva colaboración para ampliar drásticamente ... con cáncer en los Estados Unidos   ... Health proporcionarán a los pacientes con cáncer apoyo ... Guardian Research Network y Molecular Health han anunciado ...
Breaking Medicine Technology:Astellas Announces Preliminary Phase 1/2 Safety, Tolerability And Efficacy Data For ASP2215 In Patients With Relapsed Or Refractory Acute Myeloid Leukemia (AML) 2Astellas Announces Preliminary Phase 1/2 Safety, Tolerability And Efficacy Data For ASP2215 In Patients With Relapsed Or Refractory Acute Myeloid Leukemia (AML) 3OncoGenex Announces Data from the Phase 3 SYNERGY Trial Showing a Survival Benefit with Custirsen in Patients with Poor Prognosis 2OncoGenex Announces Data from the Phase 3 SYNERGY Trial Showing a Survival Benefit with Custirsen in Patients with Poor Prognosis 3OncoGenex Announces Data from the Phase 3 SYNERGY Trial Showing a Survival Benefit with Custirsen in Patients with Poor Prognosis 4OncoGenex Announces Data from the Phase 3 SYNERGY Trial Showing a Survival Benefit with Custirsen in Patients with Poor Prognosis 5OncoGenex Announces Data from the Phase 3 SYNERGY Trial Showing a Survival Benefit with Custirsen in Patients with Poor Prognosis 6Nueva colaboración para ampliar el acceso al ensayo clínico terapéutico para pacientes con cáncer en EEUU 2Nueva colaboración para ampliar el acceso al ensayo clínico terapéutico para pacientes con cáncer en EEUU 3Nueva colaboración para ampliar el acceso al ensayo clínico terapéutico para pacientes con cáncer en EEUU 4
... Masimo (NASDAQ: MASI ) announced today that ... (RRa™) was presented at the New York ... Meeting in New York City. The new ... outcomes and patient safety impact of Masimo,s unique Acoustic Respiration ...
... /PRNewswire-iReach/ -- Physicians, Capital Investments, LLC (PCI/the ... and medical investment solutions is pleased to announce ... to Dallas, TX. The new headquarters, centrally located ... Company,s real estate development, business development and administrative ...
Cached Medicine Technology:New Clinical Study Presented at the NYPGA Meeting Shows Respiration Rate Monitoring -- Considered the Fourth Primary Vital Sign -- Has Been Revolutionized With Masimo rainbow Acoustic Monitoring Technology 2New Clinical Study Presented at the NYPGA Meeting Shows Respiration Rate Monitoring -- Considered the Fourth Primary Vital Sign -- Has Been Revolutionized With Masimo rainbow Acoustic Monitoring Technology 3New Clinical Study Presented at the NYPGA Meeting Shows Respiration Rate Monitoring -- Considered the Fourth Primary Vital Sign -- Has Been Revolutionized With Masimo rainbow Acoustic Monitoring Technology 4New Clinical Study Presented at the NYPGA Meeting Shows Respiration Rate Monitoring -- Considered the Fourth Primary Vital Sign -- Has Been Revolutionized With Masimo rainbow Acoustic Monitoring Technology 5Physicians' Capital Investments Announces Relocation of its Corporate Headquarters to Dallas, TX 2Physicians' Capital Investments Announces Relocation of its Corporate Headquarters to Dallas, TX 3
(Date:5/29/2015)... Displays and Exhibits’ has recently aligned with a new hanging ... signs ; making what was formerly an elite expensive ... points at a usual height of 16’-20’ are easily seen ... are very unique and more visible than the largest exhibits. ... labor and rigging the costs far outweigh the benefit of ...
(Date:5/29/2015)... 2015 Based in St. Louis, Missouri La ... for a couple of months now and are really ... which reads “I’m not misbehaving, I have Autism, please be ... of an autistic child in order to start a conversation ... only are they raising awareness through the autism awareness shirts ...
(Date:5/29/2015)... What does community do? , According to ... together to plant gardens, to teach young people, to ... critical issues. Community invites everyone to help improve lives ... Community Does" was commissioned by The Denver Foundation, the ... during the foundation’s Annual Celebration in May. At just ...
(Date:5/29/2015)... May 29, 2015 M3 USA MDLinx.com, ... in 14 medical specialties, now offers The Smartest ... spectrum of rheumatology disorders ranging from Fibromyalgia and Osteoporosis, ... editorial director of MDLinx, and Caroline Tredway, editorial head ... impact it will have on the physicians who participate. ...
(Date:5/29/2015)... Cincinnati, Ohio (PRWEB) May 29, 2015 ... Proven Experience to Cincinnati , The Department of Veterans ... John A. Gennaro as the new director of the ... of health care to more than 43,000 unique Veterans ... , With over 2,000 staff, CVAMC is a two-division ...
Breaking Medicine News(10 mins):Health News:Displays and Exhibits Announces New Hanging Sign Supplier 2Health News:La La Land Shirts Is Busy Spreading Autism Awareness with Complimentary Shipping on Their New Shirt 2Health News:What Community Does: A New Video from The Denver Foundation 2Health News:MDLinx Launches Smartest Rheumatologist 2Health News:VA Healthcare System of Ohio Network Announces New Medical Center Director 2
... ... promotes Prize4Life. , ... (Vocus) March 24, 2010 -- In April of 2009, Director/Producer James Takata, Writers/Producers Zach ... Prize4Life’s battle against ALS. Trapped is a short film about Stephen, a talented young ...
... in Spanish . Barcelona, Spain: Recurrence ... tumour remains the strongest, independent prognostic factor for subsequent metastasis ... disease for a very long time, according to research presented ... Dr Sven Mieog, MD, a research fellow at Leiden ...
... release is available in Spanish . ... women are surviving breast cancer and delaying childbirth, it is ... fertility into consideration when deciding on treatment, the seventh European ... Dr. Anne Armstrong, from the Department of Medical Oncology, the ...
... after the death of a loved one can provide much-needed ... a study in the April issue of the Journal ... lost a relative to cancer took part in the study. ... included widows, widowers, daughters and sisters. Nine chose foot massage, ...
... Organic Relaxation Herbal ... the product works. This Herbal Tea can be purchased at Youmeandtea.com, , , ... (PRWEB) March 24, 2010 -- Organic Relaxation ... well the product works. This Herbal Tea can be purchased at Youmeandtea.com , ,"I ...
... ... obesity and empower kids to make healthy decisions. , ... (Vocus) March 24, 2010 -- To help kids to make healthy ... www.mvpkidpower.com on Facebook., , , , ,“Being on Facebook enables KidPower to actually ...
Cached Medicine News:Health News:Prize4Life Inspires Award-winning ALS Film: Trapped 2Health News:Prize4Life Inspires Award-winning ALS Film: Trapped 3Health News:Recurrence of breast cancer after more than 10 years is an important indicator of survival 2Health News:Recurrence of breast cancer after more than 10 years is an important indicator of survival 3Health News:Fertility issues in young women with breast cancer must be addressed 2Health News:Hand and feet massages provide consolation for bereaved relatives 2Health News:Snoring Reduced With Relaxation Tea… Could It Be? 2Health News:Snoring Reduced With Relaxation Tea… Could It Be? 3Health News:MVP Health Care Takes KidPower Youth Sports Program to Facebook 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: